Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Novel cannabinoid CB2 receptor modulator tested in mice with TBI

Nov. 28, 2013

TR-L-382 plus pregabalin shows promise in preclinical models of neuropathic pain

Nov. 28, 2013

Nanomerics presents in vivo results for novel nanoparticle LENK formulation

Nov. 28, 2013

QRxPharma refiles MoxDuo NDA

Nov. 27, 2013

FDA accepts Targiniq ER NDA for review

Nov. 27, 2013

Summit and the University of Oxford to develop treatments for DMD

Nov. 27, 2013

Preclinical findings suggest diminished abuse potential for MG-01CI

Nov. 26, 2013

Anafranil approved for new indication in Japan

Nov. 26, 2013

FDA grants fast track designation to Cerecor's CERC-301 for major depressive disorder

Nov. 26, 2013

First-in-human results support proof of mechanism for MAO-B inhibition by YKP-10461

Nov. 26, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...